EXAGEN INC. Contracts & Agreements

Description of Securities (Filed With SEC on March 18, 2024)

Consulting Agreement, dated as of December 6, 2023, by and between the Company and Mark Hazeltine (Filed With SEC on December 11, 2023)

Amendment No. 1, dated November 17, 2023, to the Sales Agreement, dated as of September 15, 2022, by and between Exagen Inc. and Cowen and Company, LLC (Filed With SEC on November 17, 2023)

Assignment and Assumption Agreement, by and among Liberty Vista, L.P., Mindera Corporation and the Company (Filed With SEC on November 13, 2023)

Exagen Inc. Clawback Policy (Filed With SEC on November 13, 2023)

Third Amendment to Loan and Security Agreement dated April 28, 2023, by and among Innovatus Life Sciences Lending I, LP, other lenders and the Company (Filed With SEC on May 4, 2023)

Consulting Agreement, dated as of December 5, 2022, by and between the Company and Debra Zack, M.D., Ph.D (Filed With SEC on December 5, 2022)

Employment Agreement, dated as of October 16, 2022, by and between the Company and John Aballi (Filed With SEC on October 20, 2022)

Severance Agreement, dated as of October 14, 2022, by and between the Company and Fortunato Ron Rocca (Filed With SEC on October 20, 2022)

Sales Agreement, dated as of September 15, 2022, by and between Exagen Inc. and Cowen and Company, LLC (Filed With SEC on September 15, 2022)

Exagen Inc. Amended and Restated Executive Change in Control and Severance Plan (Filed With SEC on May 11, 2022)

Exagen Inc. Amended and Restated Executive Change in Control and Severance Plan (Filed With SEC on April 28, 2022)

Sublease Agreement, dated August 19, 2021, by and between Plum Healthcare Group, LLC and the Company (Filed With SEC on November 10, 2021)

Second Amendment to Standard Industrial/Commercial Single-Tenant Lease, dated October 11, 2021, by and between Liberty Vista and the Company (Filed With SEC on November 10, 2021)

Fifth Amendment to Standard Industrial/Commercial Multi-Tenant Lease, dated October 19, 2021, by and between RGS Properties and the Company (Filed With SEC on November 10, 2021)

First Amendment to Standard Industrial/Commercial Multi-Tenant Lease, dated October 19, 2021, by and between RGS Properties and the Company (Filed With SEC on November 10, 2021)

Second Amendment to Loan and Security Agreement dated November 1, 2021, by and among Innovatus Life Sciences Lending I, LP, other lenders and the Company (Filed With SEC on November 10, 2021)

Letter Agreement, dated September 28, 2021, by and between the Company and Prometheus Laboratories Inc (Filed With SEC on November 10, 2021)

Form of Exchange Warrant (Filed With SEC on August 9, 2021)

Amendment #4 to Co-Promotion Agreement, dated June 30, 2021 (Filed With SEC on August 9, 2021)

Underwriting Agreement, dated March 22, 2021, by and among Exagen Inc. and Cowen and Company, LLC, William Blair & Company, L.L.C. and Cantor Fitzgerald & Co., as representatives... (Filed With SEC on March 23, 2021)

Form of Restricted Stock Unit Agreement under Exagen Inc. 2019 Incentive Award Plan (Filed With SEC on March 16, 2021)

Amendment #3 to Co-Promotion Agreement, dated December 23, 2020, by and between Janssen Biotech, Inc. and the Registrant (Filed With SEC on March 16, 2021)

First Amendment to Standard Industrial/Commercial Single-Tenant Lease, dated January 6, 2021, by and between Liberty Vista and the Registrant (Filed With SEC on March 16, 2021)

Executive Change in Control Severance Plan (Filed With SEC on March 16, 2021)

Acknowledgement Letter to Loan and Security Agreement, by and between Innovatus Life Sciences Lending I, LP and the Registrant (Filed With SEC on November 10, 2020)

Amendment #1 to Co-Promotion Agreement, dated January 1, 2019, by and between Janssen Biotech, Inc. and the Registrant (Filed With SEC on July 28, 2020)

Amendment #2 to Co-Promotion Agreement, dated June 18, 2020, by and between Janssen Biotech, Inc. and the Registrant (Filed With SEC on July 28, 2020)

Second Amendment to Standard Industrial/Commercial Multi-Tenant Lease, dated April 29, 2016, by and between RGS Properties and the Registrant (Filed With SEC on March 25, 2020)

Third Amendment to Standard Industrial/Commercial Multi-Tenant Lease, dated June 16, 2017, by and between RGS Properties and the Registrant (Filed With SEC on March 25, 2020)

Fourth Amendment to Standard Industrial/Commercial Multi-Tenant Lease, dated March 16, 2020, by and between RGS Properties and the Registrant (Filed With SEC on March 25, 2020)

First Amendment to Standard Industrial/Commercial Single-Tenant Lease, dated August 2, 2017, by and between Geiger Court, LLC and the Registrant (Filed With SEC on March 25, 2020)

Extension of Lease to Standard Industrial/Commercial Single-Tenant Lease, dated March 12, 2020, by and between Liberty Vista and the Registrant (Filed With SEC on March 25, 2020)

Standard Industrial/Commercial Multi-Tenant Lease, dated March 17, 2020 by and between RGS Properties and the Registrant (Filed With SEC on March 25, 2020)

First Amendment to Loan and Security Agreement with Innovatus Life Sciences Lending I, LP dated November 19, 2019 (Filed With SEC on March 25, 2020)

Offer Letter dated February 21, 2020, by and between Debra Zack (Filed With SEC on March 25, 2020)

Specimen stock certificate evidencing the shares of common stock (Filed With SEC on September 9, 2019)

Exagen Inc. 2019 Incentive Award Plan (Filed With SEC on September 9, 2019)

Form of Option Agreement under Exagen Inc. 2019 Incentive Award Plan (Filed With SEC on September 9, 2019)

Exagen Inc. 2019 Employee Stock Purchase Plan (Filed With SEC on September 9, 2019)

Offer Letter, dated October 12, 2010, by and between Thierry Dervieux, Ph.D. and the Registrant, as amended on September 9, 2011 and September 6, 2019 (Filed With SEC on September 9, 2019)

Offer Letter, dated October 7, 2011, by and between Fortunato Ron Rocca and the Registrant, as amended on September 4, 2019 (Filed With SEC on September 9, 2019)

Offer Letter, dated May 16, 2017, by and between Kamal Adawi and the Registrant, as amended on September 4, 2019 (Filed With SEC on September 9, 2019)

Non-Employee Director Compensation Program (Filed With SEC on September 9, 2019)

Form of Underwriting Agreement (Filed With SEC on August 23, 2019)

Amended and Restated Investors Rights Agreement, dated July 12, 2019, by and among the Registrant and certain of its stockholders (Filed With SEC on August 23, 2019)

Amended and Restated Stockholders Agreement, dated July 12, 2019, by and among the Registrant and certain of its stockholders (Filed With SEC on August 23, 2019)

Form of Common Stock Purchase Warrant issued to investors by the Registrant in connection with private placement financings (Filed With SEC on August 23, 2019)

Form of Preferred Stock Purchase Warrant issued to Capital Royalty Partners and related advisors by the Registrant in connection with the Term Loan Agreement, by and between... (Filed With SEC on August 23, 2019)

Form of Warrant to Purchase Shares of Preferred Stock issued to investors by the Registrant in October 2015 (Filed With SEC on August 23, 2019)

Amendment to Convertible Promissory Notes and Warrants, dated January 19, 2016 (Filed With SEC on August 23, 2019)

Form of Common Stock Purchase Warrant to purchase common stock issued to investors by the Registrant in 2016 (Filed With SEC on August 23, 2019)

Form of Warrant to Purchase Stock issued to Innovatus Life Sciences Lending Fund I, LP in connection with the Registrants 2018 loan agreement (Filed With SEC on August 23, 2019)

Exagen Corporation 2002 Stock Option Plan, as amended, and form of option agreement thereunder (Filed With SEC on August 23, 2019)

Exagen Diagnostics, Inc. 2013 Stock Option Plan, as amended, and form of option agreement thereunder (Filed With SEC on August 23, 2019)

Exagen Inc. 2019 Incentive Award Plan (Filed With SEC on August 23, 2019)

Exagen Inc. 2019 Employee Stock Purchase Plan (Filed With SEC on August 23, 2019)

License Agreement, dated September 13, 2007, by and between Prometheus Laboratories Inc. and the Registrant (as successor in interest to Proprius, Inc.) (Filed With SEC on August 23, 2019)

First Amendment to License Agreement, dated October 23, 2013, by and between Prometheus Laboratories Inc. and the Registrant (as successor in interest to Cypress Bioscience, Inc.) (Filed With SEC on August 23, 2019)

Asset Purchase Agreement, dated February 9, 2009, by and between the Registrant (as successor in interest to Cypress Bioscience, Inc.) and Cellatope Corporation (Filed With SEC on August 23, 2019)

Amendment No. One to Asset Purchase Agreement, dated December 14, 2012, by and between the Registrant and Cellatope Corporation (Filed With SEC on August 23, 2019)

Amendment No. Two to Asset Purchase Agreement, dated January 11, 2017, by and between the Registrant and Cellatope Corporation (Filed With SEC on August 23, 2019)

Asset Purchase Agreement, dated October 8, 2010, by and between Cypress Bioscience, Inc., Proprius, Inc. and the Registrant (Filed With SEC on August 23, 2019)

Amendment No. One to Asset Purchase Agreement, dated March 10, 2011, by and between Cypress Bioscience, Inc., Proprius, Inc. and the Registrant (Filed With SEC on August 23, 2019)

Amendment No. Two to Asset Purchase Agreement, dated August 21, 2012, by and between Royalty Pharma Collection Trust, Proprius, Inc. and the Registrant (Filed With SEC on August 23, 2019)

Amendment No. Three to Asset Purchase Agreement, dated February 6, 2013, by and between Royalty Pharma Collection Trust, Proprius, Inc. and the Registrant (Filed With SEC on August 23, 2019)

Amendment No. Four to Asset Purchase Agreement, dated October 8, 2013, by and between Royalty Pharma Collection Trust, Proprius, Inc. and the Registrant (Filed With SEC on August 23, 2019)

Amendment No. Five to Asset Purchase Agreement, dated January 26, 2016, by and between Royalty Pharma Collection Trust, Proprius, Inc. and the Registrant (Filed With SEC on August 23, 2019)

Amendment No. Six to Asset Purchase Agreement, dated February 16, 2017, by and between Royalty Pharma Collection Trust, Proprius, Inc. and the Registrant (Filed With SEC on August 23, 2019)

Amended and Restated Exclusive License Agreement, dated August 2, 2011, by and between the University of PittsburghOf the Commonwealth System of Higher Education and the Registrant (Filed With SEC on August 23, 2019)

First Amendment to Amended and Restated Exclusive License Agreement, dated May 17, 2012, by and between the University of PittsburghOf the Commonwealth System of Higher Education... (Filed With SEC on August 23, 2019)

Second Amendment to Amended and Restated Exclusive License Agreement, dated September 30, 2013, by and between the University of PittsburghOf the Commonwealth System of Higher... (Filed With SEC on August 23, 2019)

Third Amendment to Amended and Restated Exclusive License Agreement, dated June 24, 2016, by and between the University of PittsburghOf the Commonwealth System of Higher Education... (Filed With SEC on August 23, 2019)

Exclusive License Agreement, dated September 30, 2013, by and between the University of PittsburghOf the Commonwealth System of Higher Education and the Registrant (Filed With SEC on August 23, 2019)

Exclusive License Agreement, dated September 5, 2011, by and between Thierry Dervieux, Ph.D. and the Registrant (Filed With SEC on August 23, 2019)

Co-Promotion Agreement, dated December 10, 2018, by and between Janssen Biotech, Inc. and the Registrant (Filed With SEC on August 23, 2019)

Standard Industrial/Commercial Multi-Tenant Lease, dated January 13, 2012, by and between RGS Properties and the Registrant (Filed With SEC on August 23, 2019)

First Amendment to Standard Industrial/Commercial Multi-Tenant Lease, dated December 1, 2013, by and between RGS Properties and the Registrant (Filed With SEC on August 23, 2019)

Lease, dated May 7, 2013, by and between The Regents of the University of New Mexico and the Registrant (Filed With SEC on August 23, 2019)

First Amendment to Lease by and between The Regents of the University of New Mexico and the Registrant (Filed With SEC on August 23, 2019)

Second Amendment to Lease by and between The Regents of the University of New Mexico and the Registrant (Filed With SEC on August 23, 2019)

Third Amendment to Lease by and between The Regents of the University of New Mexico and the Registrant (Filed With SEC on August 23, 2019)

Standard Industrial/Commercial Single-Tenant Lease, dated September 4, 2014, by and between Geiger Court, LLC and the Registrant (Filed With SEC on August 23, 2019)

Master Lease Agreement, dated February 1, 2018, by and between Celtic Commercial Finance, a division of MB Equipment Finance, LLC and the Registrant (Filed With SEC on August 23, 2019)

Loan and Security Agreement, dated September 7, 2017, by and between Innovatus Life Sciences Lending Fund I, LP and the Registrant (Filed With SEC on August 23, 2019)

Offer Letter, dated October 12, 2010, by and between Thierry Dervieux, Ph.D. and the Registrant, as amended on September 9, 2011 (Filed With SEC on August 23, 2019)

Form of Indemnification Agreement for Directors and Officers (Filed With SEC on August 23, 2019)

Non-Employee Director Compensation Program (Filed With SEC on August 23, 2019)

EXAGEN DIAGNOSTICS, INC. FIFTH AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT (Filed With SEC on February 17, 2016)

EXAGEN DIAGNOSTICS, INC. FIFTH AMENDED AND RESTATED STOCKHOLDERS AGREEMENT (Filed With SEC on February 17, 2016)

WARRANT TO PURCHASE SHARES OF PREFERRED STOCK of EXAGEN DIAGNOSTICS, INC. INCORPORATED UNDER THE LAWS OF THE STATE OF DELAWARE (Filed With SEC on February 17, 2016)

AMENDMENT TO CONVERTIBLE PROMISSORY NOTES AND WARRANTS (Filed With SEC on February 17, 2016)

EXAGENDIAGNOSTICS, INC. COMMON STOCK PURCHASE WARRANT (Filed With SEC on February 17, 2016)

AMENDMENT NO. FOUR TO ASSET PURCHASE AGREEMENT AND CONSENT (Filed With SEC on February 17, 2016)

LEASE (Filed With SEC on February 17, 2016)

AMENDMENT NO. FIVE TO ASSET PURCHASE AGREEMENT (Filed With SEC on February 17, 2016)

EXAGEN DIAGNOSTICS, INC. CONVERTIBLE PROMISSORY NOTE (Filed With SEC on November 12, 2015)

EXAGEN DIAGNOSTICS, INC. CONVERTIBLE PROMISSORY NOTE (Filed With SEC on August 12, 2015)

THIRD AMENDMENT TO LEASE (Filed With SEC on August 12, 2015)

CERTAIN MATERIAL (INDICATED BY AN ASTERISK) HAS BEEN OMITTED FROM THIS DOCUMENT PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT. THE OMITTEDMATERIAL HAS BEEN FILED SEPARATELY... (Filed With SEC on February 18, 2015)

SECOND AMENDMENT TO LEASE (Filed With SEC on February 18, 2015)

EXAGEN DIAGNOSTICS, INC. (a Delaware corporation) [] Shares of Common Stock UNDERWRITING AGREEMENT (Filed With SEC on November 7, 2014)

CERTAIN MATERIAL (INDICATED BY AN ASTERISK) HAS BEEN OMITTED FROM THIS DOCUMENT PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT. THE OMITTEDMATERIAL HAS BEEN FILED SEPARATELY... (Filed With SEC on November 7, 2014)

TERM LOAN AGREEMENT dated as of October 10, 2013 between EXAGENDIAGNOSTICS, INC. as Borrower, The SUBSIDIARY GUARANTORS from Time to Time Party Hereto, and Capital RoyaltyPartners... (Filed With SEC on November 7, 2014)

EXAGEN CORPORATION STOCK OPTION PLAN (asamended) (Filed With SEC on October 9, 2014)

EXAGEN DIAGNOSTICS, INC. 2013 STOCK OPTION PLAN (Filed With SEC on October 9, 2014)

CERTAIN MATERIAL (INDICATED BY AN ASTERISK) HAS BEEN OMITTED FROM THIS DOCUMENT PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT. THE OMITTEDMATERIAL HAS BEEN FILED SEPARATELY... (Filed With SEC on October 9, 2014)

AMENDMENT NO. ONE TO ASSET PURCHASE AGREEMENT BETWEEN CYPRESS BIOSCIENCE, INC. AND CELLATOPE CORPORATION (Filed With SEC on October 9, 2014)

CERTAIN MATERIAL (INDICATED BY AN ASTERISK) HAS BEEN OMITTED FROM THIS DOCUMENT PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT. THE OMITTEDMATERIAL HAS BEEN FILED SEPARATELY... (Filed With SEC on October 9, 2014)

FORM OF INDEMNIFICATION AGREEMENT (Filed With SEC on October 9, 2014)

EMPLOYMENT AGREEMENT (Filed With SEC on October 9, 2014)

EXECUTIVE RELOCATION AGREEMENT (Filed With SEC on October 9, 2014)

EXAGEN DIAGNOSTICS, INC. FOURTH AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT (Filed With SEC on September 19, 2014)

EXAGEN DIAGNOSTICS, INC. FOURTH AMENDED AND RESTATED STOCKHOLDERS AGREEMENT (Filed With SEC on September 19, 2014)

EXAGEN DIAGNOSTICS, INC. COMMON STOCK PURCHASE WARRANT (Filed With SEC on September 19, 2014)

EXAGEN DIAGNOSTICS, INC. PREFERRED STOCK PURCHASE WARRANT (Filed With SEC on September 19, 2014)

CERTAIN MATERIAL (INDICATED BY AN ASTERISK) HAS BEEN OMITTED FROM THIS DOCUMENT PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT. THE OMITTEDMATERIAL HAS BEEN FILED SEPARATELY... (Filed With SEC on September 19, 2014)

ASSET PURCHASE AGREEMENT between: CYPRESS BIOSCIENCE, INC., a Delaware corporation and CELLATOPE CORPORATION, a Delaware corporation Dated as ofFebruary 9, 2009 ASSET PURCHASE... (Filed With SEC on September 19, 2014)

AMENDMENT NO. ONE TO ASSET PURCHASE AGREEMENT BETWEEN CYPRESS BIOSCIENCE, INC. AND CELLATOPE CORPORATION (Filed With SEC on September 19, 2014)

CERTAIN MATERIAL (INDICATED BY AN ASTERISK) HAS BEEN OMITTED FROM THIS DOCUMENT PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT. THE OMITTEDMATERIAL HAS BEEN FILED SEPARATELY... (Filed With SEC on September 19, 2014)

AMENDMENT NO. TWO TO ASSETPURCHASE AGREEMENT between: ROYALTY PHARMA COLLECTION TRUST, PROPRIUS, INC. and EXAGEN DIAGNOSTICS, INC. Datedas of August 21, 2012 AMENDMENT NO. TWO TO... (Filed With SEC on September 19, 2014)

CERTAIN MATERIAL (INDICATED BY AN ASTERISK) HAS BEEN OMITTED FROM THIS DOCUMENT PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT. THE OMITTEDMATERIAL HAS BEEN FILED SEPARATELY... (Filed With SEC on September 19, 2014)

STANDARD INDUSTRIAL/COMMERCIAL MULTI-TENANT LEASENET AIR COMMERCIAL REAL ESTATE ASSOCIATION (Filed With SEC on September 19, 2014)

LEASE OF REAL PROPERTY Between The Regents of the University of New Mexico, Landlord And Exagen Diagnostics, Inc,Tenant Date: May 7, 2013 LEASE (Filed With SEC on September 19, 2014)

FIRST AMENDMENT TO LEASE (Filed With SEC on September 19, 2014)

AIR COMMERCIAL REAL ESTATE ASSOCIATION STANDARD INDUSTRIAL/COMMERCIAL SINGLE-TENANT LEASE NET (DO NOT USE THIS FORM FOR MULTI-TENANT BUILDINGS) (Filed With SEC on September 19, 2014)

TERM LOAN AGREEMENT dated as of October 10, 2013 between EXAGENDIAGNOSTICS, INC. as Borrower, The SUBSIDIARY GUARANTORS from Time to Time Party Hereto, and Capital RoyaltyPartners... (Filed With SEC on September 19, 2014)

SECURITY AGREEMENT (Filed With SEC on September 19, 2014)

Category

Industry

Companies

Contracts

EXAGEN INC. Contracts & Agreements